Kodiak Sciences Inc. Profile Avatar - Palmy Investing

Kodiak Sciences Inc.

Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that …

Biotechnology
US, Palo Alto [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Kodiak Sciences Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Kodiak Sciences Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Kodiak Sciences Inc..

End of KOD's Analysis
CIK: 1468748 CUSIP: 50015M109 ISIN: US50015M1099 LEI: - UEI: -
Secondary Listings
KOD has no secondary listings inside our databases.